Lincoln Park Capital to invest up to $20M in Cytori Therapeutics
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Lincoln Park Capital LLC plans to invest up to $20 million in Cytori Therapeutics Inc.
The companies entered a stock purchase agreement under which Cytori Therapeutics can issue shares to the institutional investor over a 30-month period.
Funds raised will help Cytori meet its working capital requirements.
